Delivery Order SPE2DB22D1106-SPE2DB25FDUJ2

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $9.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML. The award, valued at $9,578.59, was made on August 5, 2024, with an ultimate completion date of August 6, 2024. The contract is a Firm Fixed Price delivery order, with no set-aside designation. Amerisourcebergen, through its Corporate Office Division, is a significant supplier of pharmaceutical...
This is a $13,699.28 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NEULASTA ONPRO 6 MG/0.6 ML kits, a specialty medication used for neutropenia treatment. This delivery order is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which provides a...
This is a $23,468.55 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for Neulasta OnPro 6 mg/0.6 ml kits, a specialty pharmaceutical product. The contract has a firm fixed price and has an ultimate completion date of March 4, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,729.49, is for the supply of Neulasta OnPro 6 mg/0.6 ml kits to support federal healthcare programs, particularly military and veterans' healthcare systems. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Neulasta OnPro 6 mg/0.6 ml kits. The delivery order, valued at $7,092.23, is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,043.64, is for the delivery of Neulasta OnPro 6 mg/0.6 ml kits, a specialty medication used in the treatment of certain medical conditions. The contract is a firm fixed-price delivery order with a completion date of March 12, 2024. This award is not designated as a set-aside contract....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Neulasta OnPro 6 mg/0.6 ml kits. The order, valued at $6,176.80, has a completion date of February 8, 2024. Amerisourcebergen Drug Corp provides pharmaceuticals, medical supplies, and related distribution services to support military treatment programs and facilities under an indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,349.28 firm fixed-price delivery order is for the supply of the drug Neulasta OnPro, a biologic medication used to help prevent infections in cancer patients undergoing chemotherapy. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2022. It...
This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.78 firm fixed-price delivery order is for the supply of NEUPOGEN 300 MCG/ML VIALML, a specialty pharmaceutical product, with a contract period ending on February 6, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDUJ2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,349.28 fixed-price contract is for the supply of NEULASTA ONPRO 6 MG/0.6 ML KIT 0.6ML, a specialized pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, through its expertise in pharmaceutical distribution and medical supply procurement.

Generated 4/16/25, 5:47 PM